2019 Q1 Form 10-Q Financial Statement
#000156459019017198 Filed on May 08, 2019
Income Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $4.480M | $3.460M |
| YoY Change | 29.48% | 67.15% |
| % of Gross Profit | ||
| Research & Development | $16.51M | $13.03M |
| YoY Change | 26.72% | 86.87% |
| % of Gross Profit | ||
| Depreciation & Amortization | $637.0K | $502.0K |
| YoY Change | 26.89% | 434.04% |
| % of Gross Profit | ||
| Operating Expenses | $19.74M | $16.48M |
| YoY Change | 19.75% | 82.32% |
| Operating Profit | -$19.74M | -$16.48M |
| YoY Change | 19.75% | 82.32% |
| Interest Expense | $1.006M | $352.0K |
| YoY Change | 185.8% | 225.93% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$36.00K | $0.00 |
| YoY Change | ||
| Pretax Income | -$18.77M | -$16.13M |
| YoY Change | 16.37% | 80.63% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$18.77M | -$16.13M |
| YoY Change | 16.33% | 80.58% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$4.45 | -$47.44 |
| COMMON SHARES | ||
| Basic Shares Outstanding | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $150.2M | $134.0M |
| YoY Change | 12.09% | |
| Cash & Equivalents | $35.70M | $62.75M |
| Short-Term Investments | $115.9M | $71.30M |
| Other Short-Term Assets | $1.600M | $2.400M |
| YoY Change | -33.33% | |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $0.00 | |
| Other Receivables | $0.00 | |
| Total Short-Term Assets | $151.8M | $136.4M |
| YoY Change | 11.26% | |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $5.900M | $6.591M |
| YoY Change | -10.48% | |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $0.00 | |
| YoY Change | ||
| Other Assets | $3.100M | $522.0K |
| YoY Change | 493.87% | |
| Total Long-Term Assets | $9.000M | $7.663M |
| YoY Change | 17.45% | |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $151.8M | $136.4M |
| Total Long-Term Assets | $9.000M | $7.663M |
| Total Assets | $160.8M | $144.1M |
| YoY Change | 11.59% | |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $4.100M | $5.037M |
| YoY Change | -18.6% | |
| Accrued Expenses | $6.600M | $5.600M |
| YoY Change | 17.86% | |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $11.11M | $10.66M |
| YoY Change | 4.2% | |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $3.100M | $101.0K |
| YoY Change | 2969.31% | |
| Total Long-Term Liabilities | $3.100M | $101.0K |
| YoY Change | 2969.31% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $11.11M | $10.66M |
| Total Long-Term Liabilities | $3.100M | $101.0K |
| Total Liabilities | $14.20M | $13.83M |
| YoY Change | 2.71% | |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$103.0M | |
| YoY Change | ||
| Common Stock | $329.2M | $1.000K |
| YoY Change | 32922900.0% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $146.6M | -$98.63M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $160.8M | $144.1M |
| YoY Change | 11.59% |
Cashflow Statement
| Concept | 2019 Q1 | 2018 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$18.77M | -$16.13M |
| YoY Change | 16.33% | 80.58% |
| Depreciation, Depletion And Amortization | $637.0K | $502.0K |
| YoY Change | 26.89% | 434.04% |
| Cash From Operating Activities | -$20.60M | -$11.88M |
| YoY Change | 73.32% | 51.18% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $207.0K | $101.0K |
| YoY Change | 104.95% | -65.65% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $40.27M | $13.05M |
| YoY Change | 208.58% | -122.04% |
| Cash From Investing Activities | $40.06M | $12.95M |
| YoY Change | 209.42% | -121.76% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 282.0K | 54.39M |
| YoY Change | -99.48% | 581.09% |
| NET CHANGE | ||
| Cash From Operating Activities | -20.60M | -11.88M |
| Cash From Investing Activities | 40.06M | 12.95M |
| Cash From Financing Activities | 282.0K | 54.39M |
| Net Change In Cash | 19.75M | 55.46M |
| YoY Change | -64.39% | -193.39% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$20.60M | -$11.88M |
| Capital Expenditures | $207.0K | $101.0K |
| Free Cash Flow | -$20.80M | -$11.98M |
| YoY Change | 73.59% | 46.97% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
115949000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
324663000 | |
| CY2018Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
2059000 | |
| CY2019Q1 | ubx |
License Agreement Contingent Consideration Liability Current
LicenseAgreementContingentConsiderationLiabilityCurrent
|
446000 | |
| CY2018Q4 | ubx |
License Agreement Contingent Consideration Liability Current
LicenseAgreementContingentConsiderationLiabilityCurrent
|
895000 | |
| CY2019Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11111000 | |
| CY2019Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
2265000 | |
| CY2019Q1 | ubx |
License Agreement Contingent Consideration Liability Noncurrent
LicenseAgreementContingentConsiderationLiabilityNoncurrent
|
792000 | |
| CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
4000 | |
| CY2019Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
329226000 | |
| CY2019Q1 | ubx |
Related Party Promissory Notes For Purchase Of Common Stock
RelatedPartyPromissoryNotesForPurchaseOfCommonStock
|
201000 | |
| CY2019Q1 | ubx |
Employee Promissory Notes For Purchase Of Common Stock
EmployeePromissoryNotesForPurchaseOfCommonStock
|
400000 | |
| CY2019Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16505000 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
42888359 | |
| CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
42888359 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
6225000 | |
| CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
19737000 | |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19737000 | |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16482000 | |
| CY2019Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1006000 | |
| CY2018Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
352000 | |
| CY2019Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
36000 | |
| CY2018Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
3000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18767000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16133000 | |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
114000 | |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-34000 | |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-18653000 | |
| CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-16167000 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.44 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-4.69 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
42190457 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3437345 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
300000 | |
| CY2019Q1 | ubx |
Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
|
207000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1997000 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2059000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-83113000 | |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
31000 | |
| CY2018Q1 | ubx |
Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
|
38000 | |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1370000 | |
| CY2018Q1 | ubx |
Receipt Of Promissory Note From Related Party To Purchase Common Stock
ReceiptOfPromissoryNoteFromRelatedPartyToPurchaseCommonStock
|
390000 | |
| CY2018Q1 | ubx |
Receipt Of Promissory Note From Employees To Purchase Common Stock
ReceiptOfPromissoryNoteFromEmployeesToPurchaseCommonStock
|
400000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-98631000 | |
| CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
637000 | |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
502000 | |
| CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
366000 | |
| CY2018Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
33000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1997000 | |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1370000 | |
| CY2019Q1 | ubx |
Accretion Of Tenant Improvement Allowance
AccretionOfTenantImprovementAllowance
|
152000 | |
| CY2018Q1 | ubx |
Accretion Of Tenant Improvement Allowance
AccretionOfTenantImprovementAllowance
|
152000 | |
| CY2018Q1 | ubx |
Increase Decrease In Contribution Receivable
IncreaseDecreaseInContributionReceivable
|
-1382000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-188000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-291000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
9000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
4000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-776000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1830000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2117000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1223000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
65000 | |
| CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
239000 | |
| CY2019Q1 | ubx |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-51000 | |
| CY2018Q1 | ubx |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
48000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20596000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-11883000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
18054000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
19746000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
58321000 | |
| CY2018Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
19273000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
207000 | |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
101000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
40060000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
12947000 | |
| CY2018Q1 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
54951000 | |
| CY2019Q1 | ubx |
Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options Net Of Repurchase Payments
ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsNetOfRepurchasePayments
|
300000 | |
| CY2018Q1 | ubx |
Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options Net Of Repurchase Payments
ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsNetOfRepurchasePayments
|
27000 | |
| CY2018Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
569000 | |
| CY2019Q1 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
18000 | |
| CY2018Q1 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
17000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
282000 | |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
54392000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
55456000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
15949000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7848000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
35695000 | |
| CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
63304000 | |
| CY2019Q1 | us-gaap |
Stock Issued1
StockIssued1
|
2059000 | |
| CY2019Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
71000 | |
| CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
34000 | |
| CY2018Q1 | ubx |
Deferred Offering Costs Included In Accrued Liabilities And Accounts Payable
DeferredOfferingCostsIncludedInAccruedLiabilitiesAndAccountsPayable
|
1138000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
1517000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
5373000 | |
| CY2019Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2018Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.33898 | |
| CY2018Q2 | ubx |
Stockholders Equity Reverse Stock Split Effective Date
StockholdersEquityReverseStockSplitEffectiveDate
|
2018-04-20 | |
| CY2019Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | |
| CY2018Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
1700000 | |
| CY2019Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
1446000 | |
| CY2018Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
550000 | |
| CY2019Q1 | us-gaap |
Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk
ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk
|
As of March 31, 2019, the Company had no off-balance sheet concentrations of credit risk. | |
| CY2019Q1 | ubx |
Concentration Risk Credit Risk Off Balance Sheet Risk
ConcentrationRiskCreditRiskOffBalanceSheetRisk
|
0 | |
| CY2019Q1 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
|
2000000 | |
| CY2019Q1 | ubx |
Fair Value Assets Hierarchy Levels Transfers Amount
FairValueAssetsHierarchyLevelsTransfersAmount
|
0 | |
| CY2018 | ubx |
Fair Value Assets Hierarchy Levels Transfers Amount
FairValueAssetsHierarchyLevelsTransfersAmount
|
0 | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
145169000 | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
30000 | |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
11000 | |
| CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
145188000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
169962000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
4000 | |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
99000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
169867000 | |
| CY2019Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | |
| CY2019Q1 | ubx |
Compound Library And Option Agreement Execution Month And Year
CompoundLibraryAndOptionAgreementExecutionMonthAndYear
|
2016-02 | |
| CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-bottom:14pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:14pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed financial statements have been prepared in accordance with GAAP, which requires management to make estimates and assumptions that affect the amounts and disclosures reported in the condensed financial statements and accompanying notes. The Company bases its estimates on historical experience and market-specific or other relevant assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s condensed balance sheets and the amount of expenses and income reported for each of the periods presented are affected by estimates and assumptions, which are used for, but are not limited to, determining the fair value of assets and liabilities, common stock valuation, contingent consideration liability and stock-based compensation. Actual results could differ from such estimates or assumptions.</p> | |
| CY2019Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-bottom:14pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Risk </p> <p style="text-align:justify;margin-bottom:14pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash and marketable securities. Substantially all of the Company’s cash and cash equivalents and restricted cash is deposited in accounts with financial institutions that management believes are of high credit quality. Such deposits have and will continue to exceed federally insured limits. The Company maintains its cash with accredited financial institutions, and accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses on its cash deposits. </p> <p style="text-align:justify;margin-bottom:14pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s investment policy limits investments to certain types of securities issued by the U.S. government, its agencies and institutions with investment-grade credit ratings and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash, cash equivalents, restricted cash and marketable securities and issuers of marketable securities to the extent recorded on the balance sheets. As of March 31, 2019, the Company had no off-balance sheet concentrations of credit risk. </p> <p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company depends on third-party suppliers for key raw materials used in its manufacturing processes and is subject to certain risks related to the loss of these third-party suppliers or their inability to supply the Company with adequate raw materials. </p> | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
6230000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
5859000 | |
| CY2019Q1 | ubx |
Operating Leases Future Minimum Payments Due2023 And Later
OperatingLeasesFutureMinimumPaymentsDue2023AndLater
|
33658000 | |
| CY2019Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
52637000 | |
| CY2019Q1 | ubx |
Number Of Promissory Note
NumberOfPromissoryNote
|
3 | |
| CY2019Q1 | ubx |
Number Of Executive Officer
NumberOfExecutiveOfficer
|
2 | |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1997000 | |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1370000 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5994009 | |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
38727221 |
